3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Retention
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Lung Neoplasms
1
Lower Urinary Tract Symptoms
1
Interventions
Dutasteride
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
proxalutamide
1
polyphenon E
1
mirabegron
1
TroVax
1
Transurethral Resection of Prostate
1
Transurethral Resection of Bladder
1
Therapeutics
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prostatectomy
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Lycopene
1
Levofloxacin
1
Finasteride
1
Electroacupuncture
1
Doxazosin
1
Docetaxel
1
Diclofenac
1
Dexmedetomidine
1
Cystoscopy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Hyperplasia
×
Catheters, Indwelling
×
Clear all
NCT05851521
2023-05-09
HERMES
Lyx Institute
Phase NA
Unknown
120 enrolled